15-Apr-2020 - Max-Planck-Institut für Infektionsbiologie

Using alveolar epithelia as a model for corona infection

Researchers are using organ-like cell cultures to investigate compounds to combat the new virus

Before new drugs can be administered to people, researchers first have to investigate their effects using cell cultures and animal testing. Human cell cultures are increasingly being used as a model system for this purpose. At the Max Planck Institute for Infection Biology in Berlin, a research team led by Director Thomas F Meyer has developed a model of the human lung epithelium on which to test compounds to combat the SARS-CoV-2 coronavirus.

Meyer began culturing organ-like structures – referred to as spheroids - in his laboratory in the mid-1990s, at what was then the Max Planck Institute for Biology in Tübingen. Together with surgical colleagues from the Tübingen University Clinic, Meyer created organoids from gastrointestinal epithelial tissues. At that time, the cultures were still very short-lived; since then, Meyer and his colleagues have improved their methods of cell cultivation to the point where the organoids can be kept alive almost indefinitely. The researchers currently work with epithelial organoids of the fallopian tube, cervix, prostate, gall bladder and lung.

Epithelial cells from the lung are a particular challenge, as they have the potential to differentiate into different cell types, including type I and type II pneumocytes. The primary cell cultures are developed from distal human airway epithelial cells of the lower respiratory tract, which then develop into the cells, which form the surface of the lung’s air-sacs - the alveolar epithelial cells.

The type II pneumocytes produce crucial proteins, which reduce the surface tension of the alveoli, preventing them from collapsing. Type I pneumocytes in contrast are thin, flat cells which allow for gas exchange between the alveolus and the surrounding blood capillaries. SARS-CoV-2 virus is able to attach to and infect the alveolar pneumocytes.

Thomas Meyer’s quasi-immortal lung epithelial cells therefore present a good model system for the researchers to test the effects of antiviral drugs and other inhibitors to combat the new virus. The researchers have previously used the epithelial cells to investigate influenza viruses. A feature of these primary human epithelial cells, which has particular importance for Covid-19 research, is their ACE-2 receptor, which SARS-CoV-2 uses as an entry portal. An additional advantage is that, in contrast to most other commonly used cells, these are healthy cells which - unlike tumour cell lines - give an authentic reflection of treatment with antiviral substances. This could enable rapid identification of urgently needed drugs that could be repurposed from their original medicinal use in the fight against Covid-19.

Facts, background information, dossiers

  • SARS-CoV-2
  • coronaviruses
  • organoids
  • epithelial cells
  • Covid-19

More about MPI für Infektionsbiologie

  • News

    Genotoxic E. coli “caught in the act”

    Escherichia coli bacteria are constitutive members of the human gut microbiota. However, some strains produce a genotoxin called colibactin, which is implicated in the development of colorectal cancer. While it has been shown that colibactin leaves very specific changes in the DNA of host c ... more

    Bacteria leave signature in colon cancer cells

    Some bacterial pathogens cause damage in the genomes of their infected cells which could lead to the initiation of cancer. While it is difficult to link an infection with an onset of cancer that arises many years later in life, researchers have been looking for definitive proof that such li ... more

    Immune boost against the corona virus

    The course of the corona pandemic will strongly depend on how quickly medications or vaccines against the SARS co-virus 2 can be developed. In at least one Phase III study, researchers want to investigate whether the vaccine candidate VPM1002, originally developed against tuberculosis by sc ... more

More about Max-Planck-Gesellschaft

  • News

    Microparticles with feeling

    An international research team headed by the Max Planck Institute for Marine Microbiology in Bremen, Aarhus University and the Science for Life Lab in Uppsala has developed tiny particles that measure the oxygen concentration in their surroundings. In this way, they can track fluid flow and ... more

    New method revolutionizes cancer diagnosis

    How does cancer arise? How does cellular composition influence tumor malignancy? These questions are profound and challenging to answer, but are crucial to understand the disease and find the right cure. Now, a German-Danish team led by Professor Matthias Mann has developed a ground-breakin ... more

    MCM molecules impede the formation of DNA loops

    The entire genomic material of a cell must be packed into a tiny cell nucleus in such a way, that on the one hand, it can be stored in an organized manner and, on the other hand, it can be transcribed, duplicated or repaired as needed. Different proteins are responsible for space-saving pac ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: